polysaccharide MGN3: Clinical Trials

1 trial of polysaccharide MGN3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow polysaccharide MGN3: new trials by email Literature Review of polysaccharide MGN3 trials Research Report on polysaccharide MGN3

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV
pegylated IFN, Biobran, Ribavirin - Hepatitis C, Chronic
Phase 2CompletedCairo University372012-07-012016-02-24

Conditions studied

Hepatitis C, Chronic (1)  ·  Viremia (1)

Sponsors

Cairo University (1)

Top investigators

Abdel Rahaman Zekry, PhD (1)  ·  Dalia Omran, MD (1)  ·  Hany Khattab, MD (1)  ·  Hosny Salama, MD (1)  ·  Mamdouh Ghoneum, MD (1)  ·  Mervat Al Ansary, MD (1)  ·  Nemat Kasem, MD (1)  ·  Rasha Ahmed, MD (1)  ·  Sherif Mousa, MD (1)  ·  Tarneem Darwish, MD (1)

Results publications

PMID 27799299